This study proposes a more holistic methodology to support early-stage pharmaceutical development decisions using value-focused thinking and multi-criteria decision-making.
This study proposes a more holistic methodology to support early-stage pharmaceutical development decisions using value-focused thinking and multi-criteria decision-making.